Melanoma Characteristics in Tanning Bed Users vs. Non-Users
Understanding how artificial ultraviolet radiation impacts tumor presentation is an ongoing question in clinical dermatology. Many individuals seek rapid color through indoor tanning or explore unapproved, unregulated compounds like melanotan sold online, yet concentrated UV exposure significantly alters skin cells. A 2020 research paper published in The Annals of Otology, Rhinology, and Laryngology investigated whether a history of tanning bed use alters the behavior, anatomical presentation, and staging of subsequent melanomas. By reviewing the exact findings of this single study alongside its methodological limits, readers can better understand how indoor tanning associates with clinical tumor features without overstating what the evidence proves. Anyone concerned about new or changing pigmented marks should schedule an exam with a qualified medical doctor or dermatologist.
Study Design and Patient Group
The objective of the investigation was to determine whether tanning bed usage affects the subsequent behavior of diagnosed melanomas. To examine this question, researchers performed a case series using an institutional registry to identify patients diagnosed with invasive cutaneous melanoma. Each patient included in the dataset completed a baseline health questionnaire within 1 year of biopsy.
Based on their self-reported exposure history, the investigators categorized the participants into two distinct cohorts:
- Patients with no history of UV tanning bed usage
- Patients with any history of tanning bed usage
In total, the study evaluated 141 cases. The statistical analysis looked for measurable differences between the groups across several specific clinical markers, including tumor, node, and metastasis (TNM) staging, mitotic rate, basic demographic variables, and family history of melanoma.
What the Study Found: Patient Age and Tumor Identification
The study identified clear demographic differences between those who utilized indoor tanning devices and those who did not. Within the 141 cases, a significantly higher percentage of women (48.28%) reported tanning bed usage compared to men (26.51%, P < .01). In addition to gender differences, the authors documented a significant divergence in patient age: the average age at biopsy for individuals who reported tanning bed usage was significantly lower compared to those who had not reported using a tanning bed.
The research also noted a notable difference regarding tumor identification. Patients with a history of tanning bed usage presented significantly less often with melanoma of unknown primary (MUP). In typical clinical practice, melanoma of unknown primary occurs when malignant cells are discovered in lymph nodes or internal sites without an evident primary skin lesion. Because tanning beds expose widespread areas of skin directly to artificial UV rays, primary cutaneous tumors may be more direct and visible, leading to fewer cases where the initial site remains unknown.
What the Study Found: Staging and Tumor Aggression
When assessing overall disease severity across the entire cohort, the authors initially observed no significant difference in stage at presentation between the two groups (P = .56). Mitotic rate and baseline staging appeared broadly comparable upon first evaluation.
However, the researchers performed a secondary analysis to account for differences in presentation types. Because a greater proportion of melanomas of unknown primary are mucosal in origin rather than cutaneous, the researchers re-analyzed the cohort after removing subjects presenting with MUP. When those subjects were excluded:
- Lower TNM stage at presentation was found in patients with no tanning bed melanoma compared to those with a history of tanning bed usage.
- Patients with a history of tanning bed UV exposure presented at higher comparative TNM stages once non-cutaneous mucosal presentations were removed.
This subset finding indicated that among definitively cutaneous cases with identified primary locations, individuals with previous tanning bed use presented with more advanced primary tumor stages than individuals who had never used indoor tanning devices.
What the Study Does Not Prove Regarding Survival
Although the study identified differences in age and subset TNM staging, the data revealed critical boundaries regarding tumor mortality and aggression. Most importantly, after the authors controlled for the effects of patient gender and nodal status, tanning bed usage was not a significant independent predictor of 5 year overall survival.
Even though patients in the tanning bed group were diagnosed at a significantly younger average age and presented at higher TNM stages once MUP cases were removed, they exhibited an equivalent mortality rate compared to non-users. The study does not prove that artificial tanning bed exposure creates a more lethal biological tumor subtype over a 5 year period.
Furthermore, because this report was an observational case series of 141 cases from a single institutional registry, it cannot establish direct causation. The classification of exposure relied entirely on a questionnaire filled out within 1 year of biopsy, which carries inherent recall limitations regarding exact exposure amounts and duration.
Clinical Considerations and Skin Safety
The evidence from The Annals of Otology, Rhinology, and Laryngology demonstrates that tanning bed usage correlates with earlier melanoma onset and higher cutaneous TNM staging at presentation. These findings reinforce the importance of avoiding artificial ultraviolet radiation from commercial sunbeds, sunlamps, or tanning booths.
Similarly, consumers should be cautious of unregulated tanning peptides such as melanotan I or melanotan II marketed online. These synthetic substances are unapproved, unregulated, and carry unknown health consequences. If you notice changing borders, shifting colors, or new growths on your skin, consult a licensed physician or dermatologist for a professional clinical examination.
Sources
Published October 31, 2026. Sources are linked in the text. See our Medical Disclaimer.